Mark Berry
Impact in
-
- Long-Term Effects of COVID-19
- Traumatic Brain Injury and Neurovascular Disturbances
-
- Apelin-related biomedical research
Papers in
-
- COVID-19 Clinical Research Studies 13
- SARS-CoV-2 and COVID-19 Research 2
- Infectious Encephalopathies and Encephalitis 2
- Neurology 12
- Long-Term Effects of COVID-19 11
- Co-authors
- Pavan Atluri (1 shared paper)Kevin Morine (1 shared paper)George P. Liao (1 shared paper)Vivian Hsu (1 shared paper)William Hiesinger (1 shared paper)Y. Joseph Woo (1 shared paper)Robert Gottlieb (9 shared papers)André C. Kalil (8 shared papers)
- Journals
- Clinical Infectious Diseases (5 papers)Open Forum Infectious Diseases (2 papers)Scientific Reports (1 paper)Cellular & Molecular Biology Letters (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mark Berry
20 papers receiving 262 citations
Peers
Comparison fields: 5 of 71
- Neurology 84
- Pharmacology 84
- Infectious Diseases 70
- Cellular and Molecular Neuroscience 49
- Speech and Hearing 16
Countries citing papers authored by Mark Berry
This map shows the geographic impact of Mark Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Berry more than expected).
Fields of papers citing papers by Mark Berry
This network shows the impact of papers produced by Mark Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Berry. The network helps show where Mark Berry may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Berry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 88 | |
| 2 | 2014 | 35 | |
| 3 | 2023 | 34 | |
| 4 | 2005 | 25 | |
| 5 | 2023 | 19 | |
| 6 | 2023 | 16 | |
| 7 | 2015 | 14 | |
| 8 | 2004 | 8 | |
| 9 | 2024 | 6 | |
| 10 | Certification for child protective services staff members: the Texas initiative. | 1996 | 6 |
| 11 | 2024 | 5 | |
| 12 | 2024 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 1993 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2018 | 1 |
About Mark Berry
Mark Berry is a scholar working on Infectious Diseases, Neurology, Critical Care and Intensive Care Medicine, Epidemiology and General Health Professions, having authored 23 papers that have together received 272 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (13 papers), Long-Term Effects of COVID-19 (11 papers), Intensive Care Unit Cognitive Disorders (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Infectious Encephalopathies and Encephalitis (2 papers), COVID-19 and Mental Health (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Smoking Behavior and Cessation (1 paper). The work is most often cited by research in Neurology (84 citations), Pharmacology (84 citations), Infectious Diseases (70 citations), Cellular and Molecular Neuroscience (49 citations) and Speech and Hearing (16 citations). Mark Berry has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Pavan Atluri, Kevin Morine, George P. Liao, Vivian Hsu, William Hiesinger, Y. Joseph Woo, Robert Gottlieb, André C. Kalil, Rebekah Mannix and Ronald L. Hayes. Their work appears in journals such as Clinical Infectious Diseases, Open Forum Infectious Diseases, Scientific Reports, Cellular & Molecular Biology Letters and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.